US EditionPublished • loading... • Updated
FDA Approves New Generic Abortion Pill as Lawsuit Moves to Missouri
- A federal judge transferred a lawsuit against the FDA regarding mifepristone to Missouri, ruling that Idaho, Missouri, and Kansas have no ties to Amarillo, Texas, where it was filed.
- The FDA approved a new generic version of mifepristone, which was criticized by conservatives as a betrayal, according to Health Secretary Robert F. Kennedy Jr.
- Attorneys general from several states want to limit mifepristone's use to seven weeks of pregnancy and require in-person doctor visits.
- Senator Josh Hawley criticized the FDA's decision as shocking, stating it endangers women's health and expressing a loss of confidence in the leadership at the FDA.
Insights by Ground AI
Podcasts & Opinions
191 Articles
191 Articles
Evita Solutions announced that the US FDA has approved their cheaper form of mifepristone, a pill for terminating pregnancies up to the tenth week.
This decision, which serves as a routine procedure, was strongly criticized by the president of the powerful anti-abortion association Students for Life Action.
·Paris, France
Read Full Article
The authorisation of a new generic of mifepristone in the United States revives the debate on access to abortion and provokes a strong reaction from conservative circles The American Agency for
·France
Read Full Article
Coverage Details
Total News Sources191
Leaning Left34Leaning Right46Center86Last UpdatedBias Distribution52% Center
Bias Distribution
- 52% of the sources are Center
52% Center
L 20%
C 52%
R 28%
Factuality
To view factuality data please Upgrade to Premium
